• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Pinned News

Enhertu® Plus Pertuzumab Approved In The US

Event Tracking

Dec15
AstraZeneca's Enhertu Approved for First-Line HER2-Positive Metastatic Breast Cancer Treatment
20:38
Dec14
AstraZeneca Completes tozorakimab Delivery Method Clinical Study
16:31
Dec11
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Collaboration
18:09
Syneron Bio Completes Nearly $100 Million Funding
02:41
Dec10
HSBC raised AstraZeneca target price to 16500 pence
06:19
01:07

Schedules & Filings

Schedules
Filings
Feb10
Earning Release(EST)

FY2025 Q4 Earning Release

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15.19 B, Net Income 2.533 B, EPS 0.81

AstraZeneca PLC (AZN.US) Q3 2025 Earnings Conference CallAstraZeneca PLC (AZN.US) Q3 2025 Earnings Conference Call
Sep8
Distribution Plan(EST)

Cash dividend 0.515 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMCI
7.270
+168.27%
+4.560
RADX
10.630
+149.53%
+6.370
ARTV
6.300
+90.91%
+3.000
NTCL
0.9500
+39.71%
+0.270
MASK
0.4100
+36.35%
+0.109
QIPT
3.500
+34.10%
+0.890
KXIN
4.440
+33.73%
+1.120
ASTI
4.170
+33.65%
+1.050
CLIK
7.200
+28.34%
+1.590
CLYM
3.810
+27.00%
+0.810
View More